anthrax protective antigen liposomal vaccine (NasVax)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanthrax protective antigen liposomal vaccine (NasVax)
Drug Alias NameCCS/C-PA
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionAnthrax protective antigen stimulants
TargetsAnthrax protective antigen
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSciSparc Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSciSparc Ltd
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A